Revolutionary 'Light Paint' Cancer Treatment Destroys Tumours Without Surgery
Light 'paint' cancer treatment destroys tumours

In a medical breakthrough that could transform cancer treatment, British researchers have successfully tested a revolutionary 'light paint' therapy that can seek out and destroy hard-to-reach tumours without invasive surgery.

How the Groundbreaking Treatment Works

The innovative approach combines a special cancer-targeting compound with near-infrared light to eliminate malignant cells while leaving healthy tissue untouched. Patients receive an injection of the light-sensitive drug, which accumulates in cancer cells over several days.

Doctors then use a thin fibre-optic tube to deliver precise beams of light directly to the tumour site, activating the compound and triggering the destruction of cancer cells from within.

World-First Human Trial Success

The therapy has shown remarkable success in initial trials at several UK hospitals. Researchers reported complete tumour elimination in patients with various cancers, including those in difficult-to-treat areas where conventional surgery poses significant risks.

Professor James O'Connor, who helped develop the treatment, explained: "What makes this so exciting is its precision. We're essentially painting the tumour with light and watching it disappear, without damaging surrounding healthy tissue."

Advantages Over Traditional Treatments

  • Minimally invasive procedure requiring only local anaesthesia
  • Significantly reduced recovery time compared to surgery
  • Can be repeated multiple times if needed
  • Fewer side effects than chemotherapy or radiation
  • Effective for tumours in sensitive or hard-to-reach locations

The Future of Cancer Care

While the treatment is still in early stages, researchers believe it could become a standard option for certain cancers within the next few years. The approach is particularly promising for cancers of the head, neck, and gastrointestinal tract where surgical intervention carries higher risks.

The research team is now planning larger clinical trials and exploring applications for other cancer types. This British innovation represents a significant step forward in the global fight against cancer, offering new hope where traditional treatments have limitations.